Ascentage Pharma Group International (AAPG) Receivables - Net: 2023-2025
- Ascentage Pharma Group International's Receivables - Net was N/A to $10.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $10.8 million, marking a year-over-year change of. This contributed to the annual value of $11.4 million for FY2024, which is 44.83% down from last year.
- As of Q2 2025, Ascentage Pharma Group International's Receivables - Net stood at $10.8 million, which was down 4.88% from $11.4 million recorded in Q4 2024.
- Over the past 5 years, Ascentage Pharma Group International's Receivables - Net peaked at $20.3 million during Q4 2023, and registered a low of $10.8 million during Q2 2025.
- In the last 3 years, Ascentage Pharma Group International's Receivables - Net had a median value of $11.4 million in 2024 and averaged $14.2 million.
- Data for Ascentage Pharma Group International's Receivables - Net shows a maximum YoY crashed of 43.79% (in 2024) over the last 5 years.
- Ascentage Pharma Group International's Receivables - Net (Quarterly) stood at $20.3 million in 2023, then plummeted by 43.79% to $11.4 million in 2024, then reached $10.8 million in 2025.
- Its Receivables - Net was $10.8 million in Q2 2025, compared to $11.4 million in Q4 2024 and $20.3 million in Q4 2023.
